摘要
目的探讨螺内酯干预对经皮冠状动脉介入治疗(PCI)围手术期心肌保护作用的可能机制。方法择期PCI患者121例随机分为治疗组(A组,63例)与对照组(B组,58例),A组在常规治疗基础上口服螺内酯20~40 mg/d,B组给予安慰剂。测定PCI非手术侧冠脉内术前与术后平均动脉压(MAP),同时测定并比较术后血醛固酮(Ald)、肌钙蛋白I(cTn-I)、C-反应蛋白(CRP)浓度变化。分析cTn-I变化值(ΔcTn-I)与其它变量间的相关性。结果二组术后Ald、cTn-I、CRP浓度均较术前有明显升高(P〈0.05),A组cTn-I明显低于B组(P〈0.05);A组术后的MAP均明显高于B组(P〈0.05);相关分析表明,ΔcTn-I与ΔCRP、ΔMAP间存在明显的相关性(r=0.61、r=0.38,P〈0.05)。结论螺内酯可增加PCI术后非手术侧冠脉的灌注;其机制可能与其能促进Ald的非基因组作用有关。
Objective To investigate the possible mechanism of spironolactone to protect myocardium during percataneous coronary intervention(PCI).Methods A total of 121 patients undergoing PCI were randomly divided into two groups of A(63 cases,conventional therapy plus spironolactone 20-40 mg/d) and B(58 cases,conventional therapy alone).Mean arterial pressure(MAP) of non-operated coronary artery was measured and blood aldosterone(Ald),troponin I(cTn-I) and C-reaction protein(CRP) were detected before and after PCI.The relationship between cTn-I and other datas was analysed.Results The blood levels of Ald,cTn-I and CRP were higher after PCI than those before in two groups(P0.05),which were higher in group A than those in group B(P0.05).The level of cTn-I in group A was lower than that in group B(P0.05).The MAP in group A was higher than that in group B(P0.05).The ΔcTn-I was positively correlated to ΔCRP and ΔMAP(r=0.61 and r=0.38,P0.05).Conclusion Spironolactonec could improve the perfusion of non-operated coronary artery in the patients uderwent PCI,which may be related with its non-genomic effects of Ald.
出处
《江苏医药》
CAS
CSCD
北大核心
2011年第9期1031-1033,共3页
Jiangsu Medical Journal
基金
南通市科技局指导性课题(S9930)
关键词
螺内酯
冠心病
经皮冠状动脉介入
肌钙蛋白I
Spironolactone
Coronary heart disease
Percataneous coronary intervention
Troponin-I